SNCA and Parkinson disease: Genetic and molecular events also make it easy to discover PD biomarkers; for example, overexpressed chemokines such as CCL28 are an indication of aberrant immune activation, while truncated and phosphorylated α-synuclein fragments have distinctive pathological signatures to enhance diagnostic specificity [92].